Csps trial stroke
WebResults Eighteen randomised trials comprising 11 429 participants were included in this meta-analysis. Most trials possessed low risk of bias and were of low heterogeneity. … WebSep 11, 2010 · In CSPS 2, the incidence of stroke, the primary endpoint, was extremely low in both the cilostazol and aspirin groups, in accordance with the known benefits of …
Csps trial stroke
Did you know?
WebMar 8, 2024 · Cilostazol has potential strengths for use during acute stroke, including a rapid onset of action and a low risk of bleeding. 14,-, 16 Some RCTs showed similar or … WebJun 1, 2024 · In a multicentre, open-label, randomised controlled trial across 292 hospitals in Japan, patients with high-risk non-cardioembolic ischaemic stroke identified on MRI were randomly assigned to two groups in a 1:1 ratio to receive monotherapy with either oral aspirin (81 or 100 mg, once per day) or clopidogrel (50 or 75 mg, once per day) …
WebThe combination of cilostazol with aspirin or clopidogrel had a reduced incidence of ischaemic stroke recurrence and a similar risk of severe or life-threatening bleeding compared with treatment with aspirin or clopidogrel … WebJul 10, 2024 · Background and Purpose: Cilostazol, a phosphodiesterase 3’ inhibitor, is used in Asia-Pacific countries for stroke prevention, but rarely used elsewhere. In addition to weak antiplatelet effects, i... Cilostazol …
WebPrevention Study for Antiplatelet Combination (CSPS) trial reported that, among 1879 Japanese patients with high-risk noncardioembolic ischemic stroke in the previous 8–180 days, adding cilostazol to single antiplatelet therapy with aspirin or clopidogrel reduced the annual incidence of recurrent ischemic stroke by half compared with monother - Web西洛他唑用于抗血小板联合治疗预防卒中复发研究（Cilostazol Stroke Prevention Study for Antiplatelet Combination，CSPS.com）结果表明，对于伴有颅内或颅外中重度狭窄或两个以上血管危险因素（年龄≥65岁，高血压，糖尿病，慢性肾脏疾病，外周动脉病，既往有缺血性 …
WebOct 21, 2010 · Similar Efficacy, Less Bleeding With Cilostazol vs Aspirin for Recurrent Stroke Prevention: CSPS 2 Published Final results of the CSPS 2 trial, presented earlier this year, show a similar efficacy ...
WebNational Center for Biotechnology Information how to run antivirus in windows 10WebBackground: The antiplatelet drug cilostazol is efficacious for prevention of stroke recurrence compared with placebo. We designed the second Cilostazol Stroke Prevention Study (CSPS 2) to establish non-inferiority of cilostazol versus aspirin for prevention of stroke, and to compare the efficacy and safety of cilostazol and aspirin in patients with … northern ontario travel grant formnorthern ontario towns and citiesNational Center for Biotechnology Information northern ontario traffic camerasWebJul 19, 2024 · The group that originally conducted the CSPS.com trial recently conducted a subgroup analysis of the CSPS.com trial to show that the beneficial effect of dual antiplatelet therapy (DAPT) with cilostazol over single antiplatelet therapy was more pronounced in patients with intracranial atherosclerotic disease (ICAD) than in those … how to run an unverified app on microsoftWebNov 8, 2024 · Lancet 2016; 388:365. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or … how to run ap aging in quickbooksWeb1.4 years in the Cilostazol Stroke Prevention Study for Anti-platelet Combination (CSPS.com), a randomized controlled trial (RCT).9-11 If DAPT using cilostazol is effective when started within 1 month after stroke onset, we may be able to obtain a promising therapeutic strategy by switching the as- northern ontario towns